Abbvie Inc (ABBV) concluded trading on Thursady at a closing price of $176.75, with 4.85 million shares of worth about $857.59 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 19.23% during that period and on Thursady the price saw a gain of about 0.92%. Currently the company’s common shares owned by public are about 1.77B shares, out of which, 1.76B shares are available for trading.
According to filings with the U.S. Securities and Exchange Commission (SEC), insiders took part in trade of the company’s stock for 52 times over the past 12 months. They bought 103,084 shares in 17 of the transactions. In 35 selling transactions, insiders dumped 679,252 shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
However, the stock later moved at a day high price of 177.34, or with a gain of 0.92%. Stock saw a price change of 1.34% in past 5 days and over the past one month there was a price change of 5.52%. Year-to-date (YTD), ABBV shares are showing a performance of 14.05% which increased to 16.28% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $130.96 but also hit the highest price of $178.92 during that period. The average intraday trading volume for Abbvie Inc shares is 5.39 million. The stock is currently trading 3.44% above its 20-day simple moving average (SMA20), while that difference is up 8.26% for SMA50 and it goes to 18.88% higher than SMA200.
Abbvie Inc (NYSE: ABBV) currently have 1.77B outstanding shares and institutions hold larger chunk of about 72.13% of that.
The stock has a current market capitalization of $312.22B and its 3Y-monthly beta is at 0.55. PE ratio of stock for trailing 12 months is 64.97, while it has posted earnings per share of $2.72 in the same period. Its PEG reads 19.83 and has Quick Ratio of 0.76 while making debt-to-equity ratio of 5.80. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for ABBV, volatility over the week remained 1.87% while standing at 1.89% over the month.
Analysts are in expectations that Abbvie Inc (ABBV) stock would likely to be making an EPS of $2.18 in the current quarter, while forecast for next quarter EPS is $2.59 and it is $11.31 for next year. For the current quarter EPS, analysts have given the company a lowest target $2.14 which is $2.22 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of $2.46 in the same quarter a year ago. Stock’s fiscal year EPS is expected to rise by 0.66% while it is estimated to increase by 9.15% in next year. EPS is likely to grow at an annualized rate of 3.28% for next 5-years, compared to annual growth of -5.77% made by the stock over the past 5-years.
On December 11, 2023, Goldman Upgrade their recommendations, while on November 09, 2023, Deutsche Bank Initiated their ratings for the stock with a price target of $150. Stock get an Overweight rating from Barclays on October 30, 2023.
